ViroPharma to Present at the Banc of America Securities 2005 Specialty Pharmaceuticals Conference
July 25, 2005 10:49 ET
|
ViroPharma Incorporated
EXTON, Pa., July 25, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the Banc Of America Securities 2005 Specialty Pharmaceuticals Conference, at...
ViroPharma Announces Elimination of 2009 Debt
July 05, 2005 16:47 ET
|
ViroPharma Incorporated
EXTON, Pa., July 5, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has delivered notice that it will exercise its right to automatically convert the remaining...
ViroPharma Announces Execution on Extensive Debt Reduction Effort
June 20, 2005 08:45 ET
|
ViroPharma Incorporated
EXTON, Pa., June 20, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will exercise its right to automatically convert $18.75 million principal amount of its 6%...
ViroPharma To Present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference
May 27, 2005 11:45 ET
|
ViroPharma Incorporated
EXTON, Pa., May 27, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference, at 8:20 a.m....
ViroPharma Announces Advancement of HCV-796 Into Phase 1B Clinical Testing In Hepatitis C Patients
May 24, 2005 09:40 ET
|
ViroPharma Incorporated
EXTON, Pa., May 24, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the commencement of a Phase 1b proof of concept clinical study in hepatitis C positive patients with...
ViroPharma to Present at the Fourth Annual Needham Biotechnology Conference
May 19, 2005 13:45 ET
|
ViroPharma Incorporated
EXTON, Pa., May 19, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the Fourth Annual Needham Biotechnology Conference, at 3:30 P.M. Eastern Time on...
ViroPharma to Present at the Imperial Capital 2005 Equity Conference
May 17, 2005 12:30 ET
|
ViroPharma Incorporated
EXTON, Pa., May 17, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at Imperial Capital 2005 Special Situations Equity Conference, at 2:45 P.M. Eastern...
ViroPharma To Present at the 2005 Bank Of America Securities Health Care Conference
May 13, 2005 11:01 ET
|
ViroPharma Incorporated
EXTON, Pa., May 13, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the Bank of America Securities Health Care Conference, at 6:20 p.m. Eastern Time...
ViroPharma Announces Debt Reduction Of $29 Million
May 11, 2005 08:30 ET
|
ViroPharma Incorporated
EXTON, Pa., May 11, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the purchase of $29.0 million of its outstanding 6% convertible subordinated notes due March 2007....
ViroPharma Incorporated Reports First Quarter 2005 Financial Results and Increases 2005 Vancocin Pulvules Net Sales Guidance
May 03, 2005 14:20 ET
|
ViroPharma Incorporated
EXTON, Pa., May 3, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today its financial results for the first quarter ended March 31, 2005.
Quarter ended March 31, 2005
For the...